Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NU3

Wild Type HIV-1 Protease with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2007-03-15
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)0.8
Spacegroup nameP 21 21 2
Unit cell lengths58.107, 85.971, 46.420
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.020
R-factor0.1228
Rwork0.123
R-free0.14160
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)2qci
RMSD bond length0.017
RMSD bond angle0.036
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwarePHASER
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.060
High resolution limit [Å]1.0201.020
Rmerge0.0570.383
Number of reflections113536
<I/σ(I)>2.6
Completeness [%]95.562.6
Redundancy6.83
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP5.6298Crystal was grown by the hanging-drop vapor-diffusion method at room temperature, from a 2.2 mg/ml protein solution at pH 5.6 with 0.1M MES and 0.6-0.8M sodium chloride. The inhibitor was mixed with protease in a ratio 5:1, VAPOR DIFFUSION, HANGING DROP, temperature 298K

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon